𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical significance of the tumour markers CA 125 II and CA 72-4 in ovarian carcinoma

✍ Scribed by Ute Hasholzner; Ludwig Baumgartner; Petra Stieber; Werner Meier; Wolfgang Reiter; Heike Pahl; Ahmad Fateh-Moghadam

Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
554 KB
Volume
69
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluation of five glycoprotein tumour m
Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma
✍ Kjell Grankvist; BΓΆrje Ljungberg; Torgny Rasmuson πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 53 KB πŸ‘ 1 views

Increased levels of glycoprotein tumour markers have been observed in sera of patients with renal-cell carcinoma. Five different glycoprotein markers [carcinoembryonic antigen (CEA), CA-50, CA-19-9, CA-125 and CA-15-3] were assessed in 154 consecutive patients with renal-cell carcinoma before initia

CA 125 in the monitoring of response to
CA 125 in the monitoring of response to chemotherapy of ovarian carcinoma
✍ M. Quaranta; V. Lorusso; M. Coviello; G. Micelli; A. Casamassima πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 225 KB πŸ‘ 1 views

CA 125 serum levels were assessed in 23 patients undergoing chemotherapy for advanced epithelial ovarian carcinoma (EOC). Rising, falling and unchanged levels correlated with disease in 21 out of 23 (95%) cases. Ten out of I I patients who showed objective response to chemotherapy had a decrease in

Ca 72-4 radioimmunoassay in the diagnosi
Ca 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers
✍ P. Ferroni; C. Szpak; J. W. Greiner; J. F. Simpson; F. Guadagni; W. W. Johnston; πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 739 KB

We evaluated the utility of the CA 72-4, CEA, CA 125, CA 19-9 and CA 15-3 radioimmunoassays for the detection of tumor-associated antigens (TAAs) in effusions of malignant vs. benign origin. Fluids were obtained from 51 patients with adenocarcinomas, 27 with non-epithelial malignancies, and 68 with

Ca 72-4 radioimmunoassay for the detecti
Ca 72-4 radioimmunoassay for the detection of the tag-72 carcinoma-associated antigen in serum of patients
✍ Eva J. Gero; Richard Melsheimer; Dr. David Colcher; Patrizia Ferroni; Silvia Gia πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 875 KB

Monoclonal antibody (MAbp72.3 has been greater than 6 U/ml. Approximately 40% of used to detect the presence of TAG-72 in the serum of carcinoma patients. We have developed new anti-TAG-72 MAbs and have selected one of these, CC49, as the "catcher" MAb with '251-672.3 as the detecting antibody in a